Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials
- 1 February 1999
- journal article
- research article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 163 (1), 74-80
- https://doi.org/10.1016/s0022-510x(99)00015-5
Abstract
No abstract availableKeywords
Funding Information
- European Commission (ERBCHRXCT940684)
- Teva Pharmaceutical Industries
This publication has 14 references indexed in Scilit:
- Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groupsJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Magnetic resonance imaging in the differential diagnosis and monitoring of the treatment of multiple sclerosisCurrent Opinion in Neurology, 1996
- Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosisAnnals of Neurology, 1996
- Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models.Psychological Bulletin, 1995
- The relationship between truck accidents and geometric design of road sections: Poisson versus negative binomial regressionsAccident Analysis & Prevention, 1994
- Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: Statistical power of parallel-groups and crossover designsJournal of the Neurological Sciences, 1994
- Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosisBrain, 1993
- Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosisAnnals of Neurology, 1992
- Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983